Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Determination That Tovalt ODT (Zolpidem Tartrate) Orally Disintegrating Tablets, 5 Milligrams and 10 Milligrams
NoticeFDA_FRDOC_0001-14340
Comments
0
Awaiting comments
Deadline
--
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from the source system.
- Title
- Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Determination That Tovalt ODT (Zolpidem Tartrate) Orally Disintegrating Tablets, 5 Milligrams and 10 Milligrams
- Posted
- Jul 9, 2026
- Comment period
- Jul 9, 2026 – ?
- FR Doc
- 2026-13820
Analysis
Overview
No comments yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
No comments match.
